Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by MrMonkon Apr 14, 2013 10:04am
212 Views
Post# 21251922

Casey Article on the TSX.V

Casey Article on the TSX.V

This is a good article to read for those who are invested in junior resource exploration and development companies.

https://www.caseyresearch.com/cdd/tsx-v-rip

A couple of nuggets I took from the article:

 

This is all very bullish for the well-run, cashed-up juniors that are making significant, economic discoveries.

and

For example, in the latest issue of the International Speculator we initiated coverage on an exploration-stage company whose projects, according to drill data, host numerous high-grade zones of mineralization along the same geological trend as one of the Canada's biggest gold-mining operations. The company has an excellent management team and a healthy treasury. At the current price, the company is a steal.

I know for a fact that Casey's research team is aware of NOX and it sure sounds like they're talking about them.  Does anyone subscribe to International Speculator and could confirm that NOX is the company they're referencing?
 
- MM

 

<< Previous
Bullboard Posts
Next >>